|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-jRCTs031190109 |
|
Date of registration:
|
03/10/2019 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Ascorbic acid treatment for childhood Charcot-Marie-Tooth disease 1A
|
|
Scientific title:
|
Ascorbic acid treatment for childhood Charcot-Marie-Tooth disease 1A - Ascorbic acid for CMT1A |
|
Date of first enrolment:
|
25/10/2019 |
|
Target sample size:
|
12 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://jrct.niph.go.jp/latest-detail/jRCTs031190109 |
|
Study type:
|
Interventional |
|
Study design:
|
single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose
|
|
Phase:
|
2
|
|
|
Contacts
|
|
Name:
|
TADASHI
SHIOHAMA |
|
Address:
|
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, JAPAN
280-8677
Chiba
Japan |
|
Telephone:
|
+81-43-226-2144 |
|
Email:
|
asuha_hare@chiba-u.jp |
|
Affiliation:
|
Chiba University Hospital |
|
|
Name:
|
TADASHI
SHIOHAMA |
|
Address:
|
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, JAPAN
280-8677
Chiba
Japan |
|
Telephone:
|
+81-43-226-2144 |
|
Email:
|
asuha_hare@chiba-u.jp |
|
Affiliation:
|
Chiba University Hospital |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Children under 18 years of age with confirmed PMP22 duplication in genetic testing.
2. Normal data in blood examination.
3. Normal data in urinary analysis.
4. Written informed consent from the patient, or parents in case of children.
Exclusion criteria: 1. The patient has already taken daily vitamin treatment.
2. When the investigator or the investigator considers it inappropriate to conduct this study safely.
Age minimum:
Not applicable
Age maximum:
< 18age old
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
Charcot-Marie-Tooth disease type 1A
CMT1A
|
|
CMT1A
|
|
G600
|
|
Intervention(s)
|
|
ascorbic acid
|
|
ascorbic acid dayly intake
|
|
Primary Outcome(s)
|
|
CMT score
|
|
Secondary Outcome(s)
|
|
Electrophysiological examination, Six minutes walking distance
|
|
Source(s) of Monetary Support
|
|
Ethics review
|
Status: Approval
Approval date:
Contact:
prc-jim@chiba-u.jp
Chiba University Certified Clinical Research Review Board
+81-43-226-7171
prc-jim@chiba-u.jp
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|